Back
Eli Lilly and Vs. Viking Therapeutics Industry Stock Comparison
Sell
37
LLY
Eli Lilly and
Last Price:
747.82
Seasonality Move:
3.67%
Sell
38
VKTX
Viking Therapeutics
Last Price:
52.62
Seasonality Move:
50.47%
Sell
37
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $748.01. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $52.59. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $748.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $52.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -37.29 | Sell |
Relative Strength Index (14 RSI): | 32.13 | Sell |
Chaikin Money Flow: | -2278865 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (761.68 - 879.8) | Sell |
Bollinger Bands (100): | (819.36 - 941.38) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.14 | Sell |
Relative Strength Index (14 RSI): | 37.36 | Sell |
Chaikin Money Flow: | -474198 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.05 - 71.73) | Sell |
Bollinger Bands (100): | (54.01 - 67.19) | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 756.56 | Sell |
20-day SMA: | 800.8 | Sell |
50-day SMA: | 865.08 | Sell |
200-day SMA: | 834.92 | Sell |
8-day EMA: | 759.78 | Sell |
20-day EMA: | 796.19 | Sell |
50-day EMA: | 842.15 | Sell |
200-day EMA: | 811.11 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.82 | Buy |
20-day SMA: | 61.71 | Sell |
50-day SMA: | 63.78 | Sell |
200-day SMA: | 62.22 | Sell |
8-day EMA: | 53.58 | Sell |
20-day EMA: | 58.46 | Sell |
50-day EMA: | 61.44 | Sell |
200-day EMA: | 55.59 | Sell |
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.44 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.48 per share.
Eli Lilly and Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |